一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本研究通过整合TCGA和GEO数据,全面评估了LUAD样本的m6A修饰模式,同时将这些修饰模式与TME中免疫浸润细胞的特征系统关联。采用主成分分析算法构建m6A评分,以量化单个肿瘤的m6A修饰模式。
共鉴定出三种不同的 m6A 修饰模式。这三种模式中 TME 细胞浸润的特征与肿瘤的三种免疫表型高度一致,包括免疫排斥、免疫炎症和免疫惰性表型。低 m6A 评分以免疫激活和较差的生存率为特征。此外,m6A 评分与肿瘤突变负荷(TMB)相关,并能够提高 TMB 预测免疫治疗的能力。两个免疫治疗队列证实,m6A 评分较低的患者表现出显著的治疗优势和临床获益。m6A 修饰在 TME 多样性的发展中发挥重要作用。评估个体肿瘤的 m6A 修饰模式可以加深对 TME 浸润特征的理解,并指导更有效的免疫治疗策略。
OBJECT: Recent studies have demonstrated the epigenetic regulation of immune responses.
However, the potential role of N6-methyladenosine methylation (m6A) in the tumor microenvironment (TME) remains unknown. METHOD: In this study, the m6A modification patterns of LUAD samples were comprehensively evaluated by combining TCGA and GEO data, while these modification patterns were systematically linked to the characteristics of immune infiltrating cells in TME. The m6A score was constructed using the principal component analysis algorithm to quantify the m6A modification mode of a single tumor. RESULT: There were three distinct patterns of m6A modification identified. The characteristics of TME cell infiltration in these three patterns were highly consistent with these three immune phenotypes of the tumors, including immune rejection, immune-inflammatory, and immune inert phenotypes.
Low m6A scores were characterized by immune activation and poor survival rate. Besides, m6A scores were associated with tumor mutational load (TMB) and were able to increase the ability of TMB to predict immunotherapy. Two immunotherapy cohorts confirmed that the patients with lower m6A scores demonstrated significant therapeutic advantages and clinical benefits.
m6A modifications play an important role in the development of TME diversity. Assessing the m6A modification pattern of individual tumors can deepen the understanding as to the characteristics of TME infiltration and guide more effective immunotherapy strategies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。